NMRK
Newmark Group, Inc. NASDAQ Listed Dec 15, 2017$15.02
+1.01%
vs $14.87
Mkt Cap $2.3B
52w Low $11.12
44.8% of range
52w High $19.84
50d MA $15.34
200d MA $16.51
P/E (TTM)
25.2x
EV/EBITDA
8.3x
P/B
1.5x
Debt/Equity
1.1x
ROE
8.6%
P/FCF
26.7x
RSI (14)
61.30
ATR (14)
$0.54
Beta
1.83
50d MA
$15.34
200d MA
$16.51
Avg Volume
1.3M
Newmark Group, Inc. provides commercial real estate services in the United States and internationally. The company's investor/owner services and products include capital markets, such as investment, debt and structured finance, and loan sales; agency leasing, property management, and valuation and advisory; and commercial real estate due diligence consulting and advisory services, as well as government sponsored enterprise lending, loan servicing, mortgage broking, and equity-raising services. Its occupier services and products comprise tenant representation; real estate management technology systems; workplace and occupancy strategy; global corporate consulting; project management; account and transaction management; and lease administration and facilities management services. The company provides its services to commercial real estate tenants, investors, owners, occupiers, and developers, as well as lenders and multi-national corporations. As of December 31, 2021, it operated approximately 160 offices on four continents. The company was formerly known as Newmark Knight Frank and changed its name to Newmark Group, Inc. in October 2017. Newmark Group, Inc. was founded in 1929 and is based in New York, New York.
125 Park Avenue · New York City, NY 10017 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | BMO | 0.27 | 0.33 | +22.2% | 15.77 | +0.9% | +2.2% | -0.5% | -2.5% | +4.4% | +1.7% | — |
| Feb 25, 2026 | BMO | 0.65 | 0.68 | +4.6% | 14.72 | +0.8% | -0.5% | +1.6% | -2.5% | -2.3% | +2.8% | — |
| Oct 30, 2025 | BMO | 0.41 | 0.42 | +2.4% | 18.62 | +0.2% | -3.0% | -1.3% | -1.7% | +0.5% | -2.3% | — |
| Jul 30, 2025 | BMO | 0.26 | 0.31 | +19.2% | 14.44 | +4.0% | +3.2% | +1.8% | -0.3% | +2.5% | +3.0% | — |
| Apr 30, 2025 | BMO | 0.19 | 0.21 | +10.5% | 11.06 | -3.2% | -0.6% | -1.8% | +3.2% | -0.1% | -0.7% | — |
| Feb 14, 2025 | BMO | 0.48 | 0.55 | +14.6% | 13.82 | +6.9% | +6.3% | -0.9% | -0.3% | -0.6% | -1.9% | — |
| Nov 5, 2024 | BMO | 0.30 | 0.37 | +23.3% | 14.65 | -7.5% | +1.7% | -1.0% | +3.1% | +2.3% | +1.2% | — |
| Aug 2, 2024 | BMO | 0.22 | 0.22 | +0.0% | 12.74 | -3.5% | -5.3% | -4.5% | +1.8% | +0.5% | +4.3% | — |
| May 3, 2024 | BMO | 0.16 | 0.15 | -6.2% | 9.98 | +2.7% | +0.1% | +1.1% | -1.1% | +0.6% | +2.3% | — |
| Apr 26, 2024 | BMO | — | 0.21 | — | 9.66 | +0.6% | +1.0% | +0.6% | -2.5% | +0.3% | +4.0% | — |
| Nov 1, 2023 | BMO | 0.30 | 0.27 | -10.0% | 5.67 | +4.9% | +14.8% | +4.6% | +10.4% | -4.8% | -1.4% | — |
| Jul 28, 2023 | BMO | 0.23 | 0.18 | -21.7% | 6.82 | -3.1% | -0.3% | +1.8% | +0.4% | +8.2% | +1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Citizens | Maintains | Market Outperform → Market Outperform | — | $16.12 | $16.34 | +1.4% | -0.5% | -2.5% | +4.4% | +1.7% | +1.6% |
| May 1 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $16.12 | $16.34 | +1.4% | -0.5% | -2.5% | +4.4% | +1.7% | +1.6% |
| Mar 13 | Barclays | Maintains | Overweight → Overweight | — | $13.86 | $14.01 | +1.1% | +2.4% | +1.6% | +1.9% | -0.8% | +0.5% |
| Mar 2 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $14.52 | $13.80 | -5.0% | -2.3% | +2.8% | +3.4% | -2.5% | -2.9% |
| Jan 8 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $17.58 | $17.56 | -0.1% | -1.3% | -0.6% | +0.9% | -2.4% | -1.2% |
| Oct 9 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $16.91 | $17.20 | +1.7% | +1.7% | -1.2% | +2.5% | +2.9% | +2.7% |
| Aug 4 | Piper Sandler | Maintains | Overweight → Overweight | — | $15.12 | $15.33 | +1.4% | +2.5% | +3.0% | +0.4% | -0.9% | +2.3% |
| Jul 31 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $14.90 | $15.12 | +1.5% | +1.8% | -0.3% | +2.5% | +3.0% | +0.4% |
| Jul 24 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $13.27 | $13.30 | +0.2% | +1.4% | +1.0% | -0.3% | +6.6% | +3.2% |
| May 23 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $10.46 | $10.63 | +1.6% | +0.2% | +5.2% | -1.7% | +1.9% | -0.3% |
| May 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $11.13 | $11.09 | -0.4% | -0.1% | -0.7% | +1.3% | +1.3% | -0.9% |
| May 2 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $10.79 | $11.03 | +2.2% | +3.2% | -0.1% | -0.7% | +1.3% | +1.3% |
| Apr 17 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $10.36 | $10.22 | -1.4% | +0.3% | -2.9% | +2.9% | +4.3% | +3.4% |
| Mar 19 | Goldman Sachs | Maintains | Buy → Buy | — | $12.28 | $12.40 | +1.0% | +2.0% | +0.4% | -1.2% | +3.5% | -0.9% |
| Nov 25 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $15.28 | $15.05 | -1.5% | +1.6% | +0.7% | +0.0% | -1.0% | -1.1% |
| Sep 5 | Keefe, Bruyette & Woods | Upgrade | Market Perform → Outperform | — | $13.93 | $14.47 | +3.9% | +1.6% | -0.8% | +1.6% | +2.6% | -0.4% |
| Sep 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.83 | $13.72 | -0.8% | -0.3% | +1.0% | +1.6% | -0.8% | +1.6% |
| Aug 16 | Wolfe Research | Upgrade | Peer Perform → Outperform | — | $12.62 | $12.88 | +2.1% | +1.9% | +0.1% | -0.6% | +1.5% | +0.5% |
| Aug 8 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $11.80 | $12.04 | +2.0% | +4.3% | -0.3% | -2.7% | +4.3% | -0.3% |
| Jul 25 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $11.92 | $12.04 | +1.0% | +3.6% | +3.1% | -0.1% | -0.1% | +2.1% |
| Mar 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $10.84 | $10.99 | +1.4% | +0.6% | +1.7% | +0.1% | -2.0% | -2.0% |
| Feb 26 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $10.29 | $10.25 | -0.4% | +2.1% | +2.5% | -2.7% | +3.0% | -0.3% |
| Dec 20 | Piper Sandler | Upgrade | Neutral → Overweight | — | $10.07 | $10.43 | +3.6% | +1.3% | +1.8% | +0.7% | +4.3% | +2.1% |
| Oct 4 | Raymond James | Downgrade | Outperform → Market Perform | — | $5.86 | $5.58 | -4.8% | -0.5% | +1.0% | +0.0% | +2.5% | +1.7% |
| May 9 | Goldman Sachs | Maintains | Sell → Sell | — | $5.39 | $5.31 | -1.5% | -3.9% | +1.0% | +0.8% | +2.5% | +2.2% |
| May 8 | Raymond James | Maintains | Outperform → Outperform | — | $5.85 | $5.82 | -0.5% | -7.9% | -3.9% | +1.0% | +0.8% | +2.5% |
| May 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $5.85 | $5.82 | -0.5% | -7.9% | -3.9% | +1.0% | +0.8% | +2.5% |
| May 8 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $5.85 | $5.82 | -0.5% | -7.9% | -3.9% | +1.0% | +0.8% | +2.5% |
| Apr 24 | Keefe, Bruyette & Woods | Maintains | Market Perform → Market Perform | — | $6.33 | $6.32 | -0.2% | -1.4% | -3.2% | -1.7% | +4.2% | +2.4% |
| Apr 11 | Goldman Sachs | Maintains | Sell → Sell | — | $6.76 | $6.75 | -0.1% | -0.7% | -2.8% | +0.8% | -2.1% | +2.0% |
| Apr 10 | Goldman Sachs | Maintains | Sell → Sell | — | $7.12 | $6.95 | -2.4% | -5.1% | -0.7% | -2.8% | +0.8% | -2.1% |
| Feb 17 | Goldman Sachs | Maintains | Sell → Sell | — | $8.51 | $8.53 | +0.2% | -0.6% | -5.4% | +1.8% | +0.7% | -1.3% |
| Jan 20 | Raymond James | Maintains | Outperform → Outperform | — | $8.72 | $8.77 | +0.6% | +0.6% | +2.1% | -3.8% | +0.2% | +1.0% |
| Dec 12 | Goldman Sachs | Downgrade | Neutral → Sell | — | $8.33 | $7.86 | -5.6% | -6.6% | +9.0% | -0.8% | -3.4% | -2.6% |
| Nov 8 | Goldman Sachs | Maintains | Neutral → Neutral | — | $8.05 | $8.05 | +0.0% | -2.1% | -1.9% | +9.6% | +3.2% | -3.9% |
| Oct 31 | Raymond James | Maintains | Outperform → Outperform | — | $7.97 | $7.93 | -0.5% | +2.8% | +0.1% | -6.2% | -2.5% | +4.5% |
| Oct 20 | Raymond James | Maintains | Outperform → Outperform | — | $8.45 | $8.47 | +0.2% | -0.5% | +1.9% | +3.7% | +3.7% | +1.5% |
| Oct 19 | Goldman Sachs | Maintains | Neutral → Neutral | — | $8.95 | $8.75 | -2.2% | -5.6% | -0.5% | +1.9% | +3.7% | +3.7% |
| Oct 7 | Piper Sandler | Maintains | Neutral → Neutral | — | $8.86 | $8.67 | -2.1% | -5.4% | +0.2% | +1.2% | -0.8% | +2.6% |
| Jul 22 | Raymond James | Maintains | Outperform → Outperform | — | $11.17 | $11.11 | -0.5% | +0.4% | +1.0% | -0.8% | +2.4% | +1.7% |
| Apr 26 | Raymond James | Maintains | Outperform → Outperform | — | $13.11 | $12.91 | -1.5% | -2.1% | +0.2% | +4.2% | -9.4% | -1.1% |
| Apr 18 | Piper Sandler | Downgrade | Overweight → Neutral | — | $13.29 | $13.01 | -2.1% | -3.2% | +4.2% | +1.5% | -0.7% | -3.0% |
| Apr 5 | Goldman Sachs | Maintains | Neutral → Neutral | — | $15.96 | $15.63 | -2.1% | -2.8% | -6.2% | -4.5% | -2.7% | +0.2% |
| Mar 10 | Wolfe Research | Downgrade | Outperform → Peer Perform | — | $16.57 | $15.80 | -4.6% | -4.3% | -1.0% | -0.4% | -1.6% | +4.3% |
| Nov 8 | Raymond James | Maintains | Outperform → Outperform | — | $16.34 | $16.45 | +0.7% | -2.8% | +2.5% | -2.7% | +1.8% | +4.4% |
| Aug 9 | Raymond James | Maintains | Outperform → Outperform | — | $13.25 | $13.15 | -0.8% | -2.0% | +2.1% | +2.6% | -2.5% | +0.5% |
| Jun 15 | Wolfe Research | Maintains | Outperform → Outperform | — | $12.81 | $12.95 | +1.1% | +5.1% | -0.9% | -2.9% | -5.9% | +3.9% |
| Feb 19 | Goldman Sachs | Maintains | Buy → Buy | — | $9.23 | $9.44 | +2.3% | +8.5% | +1.3% | +1.0% | +2.6% | +1.1% |
| Feb 19 | Piper Sandler | Upgrade | Neutral → Overweight | — | $9.23 | $9.44 | +2.3% | +8.5% | +1.3% | +1.0% | +2.6% | +1.1% |
| Jan 22 | Raymond James | Maintains | Outperform → Outperform | — | $7.21 | $7.18 | -0.4% | +1.7% | +1.4% | -1.1% | -5.3% | +2.0% |
No insider trades available.
8-K · 8.01
!! High
Newmark Group, Inc. -- 8-K 8.01: Material Event / Announcement
May 22
8-K · 8.01
!! High
Newmark Group, Inc. -- 8-K 8.01: Material Event / Announcement
I cannot provide a meaningful analysis because the filing summary contains no substantive information about any material event or deal outcome for Newmark Group investors.
Apr 21
8-K
Newmark Group, Inc. -- 8-K Filing
Newmark Group's 8-K filing contains forward-looking statements about business operations and financial outlook that carry risks of material differences from actual results.
Feb 25
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 13,836,885 | $207M | New | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 6,285,138 | $94M | New | Mar 2026 |
| 3 | Morgan Stanley | 3,983,008 | $69M | Added | Dec 2025 |
| 4 | Westwood Holdings Group Inc | 3,212,982 | $56M | Added | Dec 2025 |
| 5 | Principal Financial Group Inc | 2,330,435 | $40M | Reduced | Dec 2025 |
| 6 | Nuveen, Llc | 2,401,330 | $36M | Added | Mar 2026 |
| 7 | Leeward Investments, Llc - Ma | 1,750,506 | $26M | Reduced | Mar 2026 |
| 8 | Systematic Financial Management Lp | 1,692,518 | $25M | Added | Mar 2026 |
| 9 | Invesco Ltd. | 1,576,678 | $24M | Reduced | Mar 2026 |
| 10 | Qube Research & Technologies Ltd | 1,469,120 | $22M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 1,468,909 | $22M | Added | Mar 2026 |
| 12 | Jpmorgan Chase & Co | 1,204,504 | $18M | Reduced | Mar 2026 |
| 13 | Bank Of New York Mellon Corp | 1,173,058 | $18M | Added | Mar 2026 |
| 14 | Raymond James Financial Inc | 1,148,073 | $17M | Reduced | Mar 2026 |
| 15 | Algert Global Llc | 1,049,122 | $16M | Added | Mar 2026 |
| 16 | Fmr Llc | 917,169 | $14M | Added | Mar 2026 |
| 17 | Prudential Financial Inc | 867,774 | $13M | Added | Mar 2026 |
| 18 | Ubs Group Ag | 822,058 | $12M | Reduced | Mar 2026 |
| 19 | Sei Investments Co | 814,101 | $12M | Added | Mar 2026 |
| 20 | Susquehanna International Group, Llp | 756,493 | $11M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$2.35B
Enterprise Value
$4.09B
P/E (TTM)
25.23x
Forward P/E
7.96x
PEG Ratio
0.25x
P/B
1.53x
P/S
1.10x
P/FCF
26.69x
EV/EBITDA
8.27x
Shares Out
253.4M
Financials (TTM)
Revenue
$3.48B
Net Income
$149.4M
EBITDA
$494.8M
Free Cash Flow
$142.6M
Op Cash Flow
$172.0M
EPS Basic
$0.71
EPS Diluted
$0.81
EPS Forward
$1.89
Gross Margin
97.3%
Op Margin
8.0%
Net Margin
4.3%
Balance Sheet
Total Assets
$5.02B
Total Liab.
$3.27B
Total Equity
$1.75B
Cash
$349.3M
LT Debt
$671.7M
Book Value/Sh
$9.82
Debt/Equity
1.14x
Current Ratio
2.25
Quick Ratio
2.25
Returns & Growth
ROE
8.6%
ROA
2.5%
ROIC
3.6%
Rev Growth YoY
+21.9%
EPS Growth YoY
+97.2%
Price Returns
2W
-5.5%
1M
-13.3%
3M
-3.8%
6M
-19.6%
12M
+26.9%
Technicals
52W High
$19.84
52W Low
$11.12
50d MA
$15.34
200d MA
$16.51
RSI (14)
61.30
ATR (14)
$0.54
Beta
1.83
Avg Volume
1.3M
Dividends
Div Rate
$0.12
Div Yield
0.8%
Frequency
4
Ex-Div Date
Mar 13, 2026
Analyst Price Targets
Consensus
$21.00
High
$21.00
Low
$21.00
Median
$21.00
Data updated apr 26, 2026 3:20pm
· Source: financialmodelingprep.com